We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
Cap. Flow
+$92.3M
Cap. Flow %
0.03%
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.37B
2
DD icon
DuPont de Nemours
DD
+$556M
3
QCOM icon
Qualcomm
QCOM
+$405M
4
MRK icon
Merck
MRK
+$333M
5
TSM icon
TSMC
TSM
+$315M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Consumer Discretionary 12.98%
3 Financials 12.81%
4 Healthcare 12.54%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPT
2826
Rithm Property Trust
RPT
$93.7M
$1.07M ﹤0.01%
16,427
+515
+3% +$34.1K
CDZI icon
2827
Cadiz
CDZI
$291M
$1.07M ﹤0.01%
111,482
+5,852
+6% +$62.8K
MG icon
2828
Mistras Group
MG
$512M
$1.07M ﹤0.01%
93,728
-21,188
-18% -$187K
HBCP icon
2829
Home Bancorp
HBCP
$566M
$1.06M ﹤0.01%
29,430
-2,366
-7% -$77.7K
COE
2830
51Talk Online Education Group
COE
$117M
$1.05M ﹤0.01%
+12,875
New +$1.24M
SB icon
2831
Safe Bulkers
SB
$774M
$1.04M ﹤0.01%
426,306
+171,923
+68% +$405K
NBEV
2832
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1.04M ﹤0.01%
365,007
-15,122
-4% -$46.2K
SRGA
2833
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$1.04M ﹤0.01%
15,966
+4,078
+34% +$285K
KZR
2834
DELISTED
Kezar Life Sciences
KZR
$1.04M ﹤0.01%
17,502
+937
+6% +$54.8K
DAKT icon
2835
Daktronics
DAKT
$1.04B
$1.03M ﹤0.01%
164,875
+10,681
+7% +$60.4K
PZN
2836
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$1.03M ﹤0.01%
97,740
-10,696
-10% -$101K
MCRB icon
2837
Seres Therapeutics
MCRB
$48.4M
$1.03M ﹤0.01%
11,075
-92
-0.8% -$42.4K
KDNY
2838
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.03M ﹤0.01%
72,635
-2,455
-3% -$40K
AAIC
2839
DELISTED
Arlington Asset Investment Corp.
AAIC
$1.02M ﹤0.01%
253,728
+17,684
+7% +$69.7K
CS
2840
DELISTED
Credit Suisse Group
CS
$1.02M ﹤0.01%
95,838
-1,290
-1% -$17.5K
PINE
2841
Alpine Income Property Trust
PINE
$352M
$1.01M ﹤0.01%
58,307
+434
+0.7% +$7.36K
PFBI
2842
DELISTED
Premier Financial Bancorp
PFBI
$1.01M ﹤0.01%
54,412
-2,459
-4% -$39.4K
SUMO
2843
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$1.01M ﹤0.01%
53,398
+863
+2% +$25.2K
YARW
2844
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$1.01M ﹤0.01%
163
-8
-5% -$58K
WMC
2845
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$1.01M ﹤0.01%
31,537
-711
-2% -$22.5K
CARE icon
2846
Carter Bankshares
CARE
$731M
$1M ﹤0.01%
94,827
-8,974
-9% -$109K
VERO
2847
DELISTED
Venus Concept
VERO
$1M ﹤0.01%
2,582
+2,283
+764% +$909K
ALTG icon
2848
Alta Equipment Group
ALTG
$245M
$1M ﹤0.01%
76,923
+8,105
+12% +$88.3K
DSGR icon
2849
Distribution Solutions Group
DSGR
$1.61B
$998K ﹤0.01%
38,466
-1,172
-3% -$30.5K
EIGR
2850
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$991K ﹤0.01%
3,731
-133
-3% -$41.9K

Similar funds

Nuveen's Q1 2021 Portfolio in Review

As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
  • Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
  • Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
  • Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
  • Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
  • Nuveen opened 118 new positions and closed 82 in Q1 2021.
  • Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.